文章摘要

参考文献/References

［1］Lutgens SP, Cleutjens KB, Daemen MJ, et al. Cathepsin cysteine proteases in cardiovascular disease［J］. Faseb J, 2007, 21(12):3029-3041.

［2］刘颖娴,李向平. 组织蛋白酶K与心血管疾病［J］. 中国动脉硬化杂志, 2008, 16(1):75-77.

［3］ Bengtsson E, Nilsson J, Jovinge S. Cystatin C and cathepsins in cardiovascular disease［J］. Front Biosci, 2008, 13:5780-5786.

［4］ Cheng XW, Kuzuya M, Nakamura K, et al. Localization of cysteine protease, cathepsin S, to the Surface of vascular smooth muscle cells by association with integrin ανβ3［J］. Am J Pathol, 2006, 168(2):685-694.

［5］ Niccoli G, Conte M, Bona RD, et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular fltration rate［J］. Atherosclerosis, 2008, 198(2):373-380.

［6］徐志强,王骏,王鸣和. 胱抑素C与冠心病相关性的研究进展［J］. 心血管病学进展, 2008, 29(1):64-67.

［7］ Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations［J］. J Endocrinol Invest, 2005, 28(4):346-349.

［8］ Punturieri A, Filippov S, Allen E, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages［J］. J Exp Med, 2000, 192(6):789-799.

［9］Lutgens E, Lutgens SP, Faber BC, et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation［J］. Circulation, 2006, 113(1):98-107.

［10］Linke M, Gordon RE, Brillard M, et al. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins［J］. Biol Chem, 2006, 387(9):1295-1303.

［11］Liu J, Sukhova GK, Sun JS, et al. Lysosomal cysteine proteases in atherosclerosis［J］. Arterioscler Thromb Vasc Biol, 2004, 24(8):1359-1366.

［12］Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms［J］. J Clin Invest, 1999, 104(9):1191-1197.

［13］Bengtsson E, To F, Grubb A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice［J］. Atherosclerosis, 2005, 180(1):45-53.

［14］Jormsj S, Wuttge DM, Sirsj A, et al. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice［J］. Am J Pathol, 2002, 161(3):939-945.

［15］Sukhova GK, Zhang Y, Pan JH, et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice［J］. J Clin Invest, 2003, 111(6):897-906.

[16]Rodgers KJ, Watkins DJ, Miller AL, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques［J］. Arterioscler Thromb Vasc Biol, 2006, 26(4):851-856.

[17]Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice［J］. Arterioscler Thromb Vasc Biol, 2005, 25(10):2151-2156.

［18］Linke M, Gordon RE, Brillard M, et al. Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins［J］. Biol Chem, 2006, 387(9):1295-1303.

[19]Cheng XW, Kuzuya M, Sasaki T, et al. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries［J］. Am J Pathol, 2004, 164(1):243-251.

[20]Burns-Kurtis CL, Olzinski AR, Needle S, et al. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit［J］. Cardiovasc Res, 2004, 62(3):610-620.

[21]Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms［J］. Arterioscler Thromb Vasc Biol, 2006, 26(5):987-994.

[22]Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms［J］. Br J Surg, 200l, 88(11):1472-1475.

[23]Yasuda Y, Li Z, Greenbaum D, et al. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages［J］. J Biol Chem, 2004, 279(35):36761-36770.

[24]Shi GP, Sukhova GK, Kuzuya M, et al. Deficiency of the cysteine protease cathepsin S impairs microvessel growth［J］. Circ Res, 2003, 92(5):493-500.

[25]Moreno PR, Purushothaman KR, Sirol M, et al. Neovascularization in human atherosclerosis［J］. Circulation, 2006, 113(18):2245-2252.

[26]Moulton KS. Angiogenesis in atherosclerosis: gathering evidence beyond speculation［J］. Curr Opin Lipidol, 2006, 17(5):548-555.

[27]Liu J, Ma LK, Yang JT. Increased serum cathepsin S in patients with atherosclerosis and diabetes［J］. Atherosclerosis, 2006,186(2):411-419.

我们的网站为什么显示成这样？

组织蛋白酶S及cystatinC与心血管疾病

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics